We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$346M
Cap. Flow
+$155M
Cap. Flow %
7.01%
Top 10 Hldgs %
52.87%
Holding
1,270
New
89
Increased
248
Reduced
136
Closed
37

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$57.1M
2
FAST icon
Fastenal
FAST
+$18.4M
3
AMZN icon
Amazon
AMZN
+$8.95M
4
DIS icon
Walt Disney
DIS
+$7.75M
5
PFE icon
Pfizer
PFE
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 26.19%
2 Financials 24.54%
3 Consumer Discretionary 15.79%
4 Communication Services 11.43%
5 Healthcare 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGA
1201
Change Agents Corp
CHGA
$2.84M
$246 ﹤0.01%
2
CRIS icon
1202
Curis
CRIS
$3.61M
0
NUGT icon
1203
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.4B
$232 ﹤0.01%
4
CGRN
1204
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$225 ﹤0.01%
40
XBIO icon
1205
Xenetic Biosciences
XBIO
$9.33M
$216 ﹤0.01%
11
EMWP
1206
DELISTED
Eros Media World PLC
EMWP
$200 ﹤0.01%
7
SPXU icon
1207
ProShares UltraPro Short S&P 500
SPXU
$387M
$182 ﹤0.01%
1
SCKT icon
1208
Socket Mobile
SCKT
$5.48M
$160 ﹤0.01%
26
HYMCZ
1209
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$134 ﹤0.01%
268
GALT icon
1210
Galectin Therapeutics
GALT
$405M
$128 ﹤0.01%
40
FRO icon
1211
Frontline
FRO
$9.84B
$126 ﹤0.01%
14
SCPX
1212
DELISTED
Scorpius Holdings, Inc.
SCPX
0
GENE
1213
DELISTED
Genetic Technologies Ltd.
GENE
$85 ﹤0.01%
4
WFRD icon
1214
Weatherford International
WFRD
$6.72B
$73 ﹤0.01%
+4
New +$68
VAL.WS icon
1215
Valaris Ltd Warrants
VAL.WS
$845M
$68 ﹤0.01%
+24
New +$52
BNBX
1216
DELISTED
BNB PLUS CORP
BNBX
0
BGMS
1217
Bio Green Med Solution Inc
BGMS
$5.7M
0
BLRX
1218
BioLineRX
BLRX
$11.4M
0
NNVC icon
1219
NanoViricides
NNVC
$31.7M
$37 ﹤0.01%
8
ELOX
1220
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
UVXY icon
1221
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
0
BNTC icon
1222
Benitec Biopharma
BNTC
$428M
0
GTE icon
1223
Gran Tierra Energy
GTE
$349M
$22 ﹤0.01%
3
GRCE
1224
Grace Therapeutics
GRCE
$44.6M
$17 ﹤0.01%
1
LSTA icon
1225
Lisata Therapeutics
LSTA
$15.2M
$16 ﹤0.01%
1

Similar funds

RBC Europe's Q2 2021 Portfolio in Review

As of Q2 2021, RBC Europe held 1,270 positions worth $2.21B, up 19% from $1.86B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

RBC Europe deployed $155M of net new capital in Q2 2021, opening 89 new positions and adding to 248 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 20,190 shares worth $1.95M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Toronto Dominion Bank, an estimated $5.8M trimmed.

  • RBC Europe's largest Q2 2021 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 20,190 shares worth $1.95M.
  • RBC Europe added most to Intercontinental Exchange in Q2 2021, an estimated $57.1M increase.
  • RBC Europe's biggest Q2 2021 reduction was Toronto Dominion Bank, cutting an estimated $5.8M.
  • RBC Europe fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.45M.
  • RBC Europe's ten largest holdings make up 53% of its $2.21B portfolio in Q2 2021.
  • RBC Europe opened 89 new positions and closed 37 in Q2 2021.
  • RBC Europe's portfolio value rose 19% quarter-over-quarter to $2.21B.

Based on RBC Europe's 13F filing for Q2 2021, filed 9 Nov 2023.